Fatty acid oxidation is also reported to be deregulated in cancer cells [46], and, in this scenario, sTWEAK might upregulate this lipolytic process by increasing CPT1 expression in the mitochondria and PNPLA2 expression in the cytoplasm, both reported to be deregulated in PCa [47,48]. The gene discussed is PNPLA2; the disease is cancer.